ArticleNature cancer2025

First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer.

Ramona Rudalska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.